ADCT vs UBER · rev $70.8M vs P/E 18, rev $52.02B
ADC Therapeutics SA (ADCT) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported ADCT revenue for 2024-12-31 was $70.8M. Net income was -$157.8M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. ADCT currently screens at market cap $141.2M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
ADCT currently screens at market cap $141.2M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the ADCT and UBER stock pages for the full models.
Not investment advice.